BSE approves HeartWorkd eLearn for TOE syllabus

RNS Number : 4855J
Medaphor Group PLC
12 September 2016
 

 

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

 

British Society of Echocardiography (BSE) approves
HeartWorks eLearn to its members for the TOE syllabus

 

MedaPhor Group plc (AIM: MED), , the global provider of advanced ultrasound skills training simulators for medical professionals, announces that HeartWorks eLearn has been approved by the British Society of Echocardiography as an educational resource for Transoesphageal Echocardiography (TOE) compatible to its syllabus and will be launched to all Society members at the forthcoming BSE Annual meeting in London.

 

HeartWorks eLearn is a web-based, interactive, self-directed learning tool for clinicians wishing to consolidate their knowledge of TOE and is ideally suited for sonographers, cardiologists, intensivists and emergency room physicians for their continued training.

 

Rick Steeds, President of the BSE, commented:

"Our close collaboration with Medaphor has been one of a number of working initiatives to provide low cost or free education to support training and career progression in echocardiography. HeartWorks is an excellent e-learning resource and a great way to cover all the education material in the BSE TOE syllabus."

 

Stuart Gall, CEO at MedaPhor, commented:

"We are delighted to be working with the BSE and supporting their wider efforts to overcome the challenges of the shortage of trained echocardiographers in the UK. We look forward to continue our working relationship with the Society as we further develop HeartWorks simulation to enable standardisation in professional practice and accreditation."

 

Enquiries:

 

MedaPhor Group plc

www.medaphor.com

Stuart Gall, CEO

Tel: +44 (0)29 2075 6534

 

 

Cenkos Securities

Tel:  +44 (0)20 7397 8900

Bobbie Hilliam (Nominated Adviser)

 

Julian Morse (Corporate Broking)

 


 

Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

 

 

About MedaPhor (www.medaphor.com)

MedaPhor (AIM: MED) is a global provider of advanced ultrasound skills training simulators for medical professionals. Founded in 2004, the Company is headquartered in Cardiff, UK and San Diego, USA, with customers in over 16 countries across the world.


Following its recent acquisition of Inventive Medical, the company now has two of the world's leading ultrasound training simulators:

 

ScanTrainer Professional, MedaPhor's market-leading ultrasound skills training simulator, offers a realistic ultrasound scanning learning experience that combines 'real-feel' haptic technology with real full anatomy patient scans, real-time one-to-one expert guidance and curriculum based teaching. The system offers trainees a flexible self-learning experience without the need for patients and with minimal requirement for expert supervision - making ScanTrainer Professional both resource efficient and highly cost effective. 

 

ScanTrainer Professional's subscription-based Cloud 2 service offers ScanTrainer users access to the unique Case Generation Engine, which enables clinicians to upload and publish their own patient scans and share these with other Cloud 2 subscribers within their organisation or around the world. In addition ScanTrainer's Cloud Case Library offers users flexible cloud-access to a growing library of nearly 300 normal and abnormal cases created using real patient scans.

 

HeartWorks, developed by leading cardiac anesthesiologists at University College London Hospitals, the HeartWorks simulators and online training materials are recognised as one of the most true-to-life and comprehensive educational tools for Transthoracic and Transoesophageal echocardiography.

 

Medical practitioners can learn, through interactive online content, the complete anatomy of the heart, view it from all angles and recognise patient cases with pathological conditions. They can then practise acquiring ultrasound images though correct probe positioning on a simulator, interpret those images to determine correct diagnosis and treatment, and finally be tested to ensure that all required competencies have been achieved to the highest standard.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAQKLFBQKFXBBV
UK 100

Latest directors dealings